Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$60.14 - $75.36 $30.1 Million - $37.7 Million
500,000 Added 125.0%
900,000 $58.5 Million
Q4 2023

Feb 14, 2024

SELL
$42.85 - $69.5 $2.14 Million - $3.48 Million
-50,000 Reduced 11.11%
400,000 $27.3 Million
Q3 2023

Nov 14, 2023

SELL
$49.5 - $66.6 $2.48 Million - $3.33 Million
-50,000 Reduced 10.0%
450,000 $23.4 Million
Q4 2022

Feb 14, 2023

BUY
$45.51 - $65.08 $6.83 Million - $9.76 Million
150,000 Added 42.86%
500,000 $28.5 Million
Q3 2022

Nov 14, 2022

BUY
$37.34 - $57.44 $13.1 Million - $20.1 Million
350,000 New
350,000 $16.4 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.26B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.